↓ Skip to main content

Norepinephrine is More Effective Than Midodrine/Octreotide in Patients With Hepatorenal Syndrome-Acute Kidney Injury: A Randomized Controlled Trial

Overview of attention for article published in Frontiers in Pharmacology, July 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Norepinephrine is More Effective Than Midodrine/Octreotide in Patients With Hepatorenal Syndrome-Acute Kidney Injury: A Randomized Controlled Trial
Published in
Frontiers in Pharmacology, July 2021
DOI 10.3389/fphar.2021.675948
Pubmed ID
Authors

Eman Ibrahim El-Desoki Mahmoud, Doaa H Abdelaziz, Sherief Abd-Elsalam, Noha O. Mansour

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Other 4 17%
Librarian 2 9%
Student > Bachelor 2 9%
Researcher 2 9%
Student > Postgraduate 2 9%
Other 0 0%
Unknown 11 48%
Readers by discipline Count As %
Medicine and Dentistry 6 26%
Pharmacology, Toxicology and Pharmaceutical Science 2 9%
Biochemistry, Genetics and Molecular Biology 2 9%
Nursing and Health Professions 1 4%
Chemical Engineering 1 4%
Other 0 0%
Unknown 11 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 June 2023.
All research outputs
#15,588,264
of 23,931,731 outputs
Outputs from Frontiers in Pharmacology
#5,673
of 17,601 outputs
Outputs of similar age
#242,243
of 444,030 outputs
Outputs of similar age from Frontiers in Pharmacology
#249
of 914 outputs
Altmetric has tracked 23,931,731 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,601 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,030 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 914 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.